Evogene Ltd
NASDAQ:EVGN

Watchlist Manager
Evogene Ltd Logo
Evogene Ltd
NASDAQ:EVGN
Watchlist
Price: 1.05 USD 0.48%
Market Cap: 9.2m USD

Wall Street
Price Targets

EVGN Price Targets Summary
Evogene Ltd

Wall Street analysts forecast EVGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVGN is 2.55 USD with a low forecast of 2.53 USD and a high forecast of 2.63 USD.

Lowest
Price Target
2.53 USD
140% Upside
Average
Price Target
2.55 USD
143% Upside
Highest
Price Target
2.63 USD
150% Upside
Evogene Ltd Competitors:
Price Targets
TLX
Telix Pharmaceuticals Ltd
128% Upside
CSL
CSL Ltd
42% Upside
RCUS
Arcus Biosciences Inc
42% Upside
214450
PharmaResearch Co Ltd
107% Upside
PBYI
Puma Biotechnology Inc
20% Downside
PRTA
Prothena Corporation PLC
114% Upside
688331
RemeGen Co Ltd
18% Upside
603087
Gan & Lee Pharmaceuticals
4% Downside

Revenue
Forecast

Revenue Estimate
Evogene Ltd

For the last 13 years the compound annual growth rate for Evogene Ltd's revenue is -4%. The projected CAGR for the next 3 years is -2%.

-4%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Evogene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Evogene Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EVGN's stock price target?
Price Target
2.55 USD

According to Wall Street analysts, the average 1-year price target for EVGN is 2.55 USD with a low forecast of 2.53 USD and a high forecast of 2.63 USD.

What is Evogene Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for Evogene Ltd's revenue is -4%. The projected CAGR for the next 3 years is -2%.

Back to Top